dr. orlowski on bortezomib added to lenalidomide and dexamethasone for multiple myeloma
Published 8 years ago • 621 plays • Length 1:32
Download video MP4
Download video MP3
Similar videos
-
1:15:33
healthtree podcast for multiple myeloma: dr. robert orlowski on myeloma in 2022
-
6:12
adding daratumumab to existing multiple myeloma regimen of lenalidomide, bortezomib and dexameth...
-
2:56
when do you use daratumumab with lenalidomide/dexamethasone or bortezomib/dexamethasone in practice?
-
16:06
griffin study: daratumumab, lenalidomide, bortezomib, and dexamethasone for multiple myeloma
-
2:34
swog s0777 trial: lenalidomide, dexamethasone and bortezomib for the treatment of mm
-
2:11
dr. robert z orlowski on the importance of the phase iii swog s0777 trial
-
0:56
bortezomib dosing for multiple myeloma
-
9:45
selinexor, bortezomib and dexamethasone shows pfs benefit for multiple myeloma
-
1:43
transplant vs bortezomib and len/dex in multiple myeloma
-
1:55
dr. mateos on ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
-
2:00
combining bortezomib and lenalidomide-based regimens for frontline mm
-
0:57
dr. rajkumar on significance of swog s0777 study for multiple myeloma
-
9:51
lenalidomide, bortezomib, and dexamethasone asct to progress for ndmm: phase 3 determination trial
-
4:29
isatuximab, lenalidomide, bortezomib and dexamethasone as induction therapy for ndmm patients
-
1:34
myeloma: pomalidomide, bortezomib and dexamethasone
-
7:09
trial results and drug combinations for bortezomib in multiple myeloma
-
55:21
the rise of novel antibodies in multiple myeloma
-
3:49
gmmg-hd4 and mm5: bortezomib vs. lenalidomide for myeloma maintenance
-
54:56
innovative therapeutic concepts for asct-eligible patients with myeloma
Clip.africa.com - Privacy-policy